UK Markets closed

STADA Arzneimittel Aktiengesellschaft (0OM4.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
93.50+2.50 (+2.75%)
At close: 5:00PM BST
Currency in EUR

Valuation measures

Market cap (intra-day) 55.81B
Enterprise value 38.34B
Trailing P/E 23.03
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)2.07
Price/book (mrq)5.72
Enterprise value/revenue 32.97
Enterprise value/EBITDA 613.78

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 393.50
52-week low 393.50
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.26M
Float 3.92M
% held by insiders 10.00%
% held by institutions 10.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 9.00%
Operating margin (ttm)16.06%

Management effectiveness

Return on assets (ttm)6.39%
Return on equity (ttm)22.55%

Income statement

Revenue (ttm)2.81B
Revenue per share (ttm)45.09
Quarterly revenue growth (yoy)16.00%
Gross profit (ttm)1.37B
EBITDA 605.48M
Net income avi to common (ttm)253.04M
Diluted EPS (ttm)4.06
Quarterly earnings growth (yoy)-35.90%

Balance sheet

Total cash (mrq)480M
Total cash per share (mrq)7.71
Total debt (mrq)2.89B
Total debt/equity (mrq)257.76
Current ratio (mrq)1.49
Book value per share (mrq)16.34

Cash flow statement

Operating cash flow (ttm)475.14M
Levered free cash flow (ttm)-485.52M